Rethinking Pharmacy Benefits: The Hidden Costs Beyond Pricing

In an era where rising prescription drug costs significantly impact employers, SHARx, a procurement management solution provider, is urging HR and CFO leaders to rethink how they approach pharmacy benefits. With both the increasing usage and costs of prescription drugs, it's clear that the effects extend beyond mere line item expenses on balance sheets. Paul Pruitt, Chief Growth Officer and Co-Founder of SHARx, emphasizes the importance of viewing pharmacy strategy as intertwined with workforce management and business priorities.

The Financial Pressure on Employers

Recent data from the Bureau of Labor Statistics highlights a concerning trend: health benefit costs for private sector employers rose by 6% year-over-year, while wages and salaries only increased by 3.1%. This discrepancy places financial strain on companies trying to maintain their investment in employee benefits. For many employers, when pharmacy expenses soar beyond budget expectations, the resulting choices boil down to whether to absorb those costs or shift them onto employees. The latter often manifests in the form of higher deductibles, increased employee contributions, and postponed improvements to benefits packages.

Pruitt notes a significant shift in employee sentiment as a consequence: they begin to question the real value of their healthcare benefits within their overall compensation. Key questions arise—can they afford to utilize those benefits? Are their health needs being adequately met? These concerns lead employees to scrutinize the effectiveness and convenience of their pharmacy benefits, redefining what a 'benefit' truly means in their lives.

Cost Control vs. Cost Shifting

While the narrative around lower drug prices circulates in the media, Pruitt cautions employers about conflating superficial cost reductions with genuine savings. To reduce costs effectively, companies must focus on lowering total pharmacy expenses through measures such as waste reduction and better sourcing rather than merely shifting costs to employees. This distinction is crucial; if employers still face significant expenses while transferring costs to employees, they have not truly solved the problem but merely relocated it—this can lead to greater access issues for employees, thereby eroding trust in the organization's commitment to their welfare.

A New Perspective on Opportunity Costs

For CFOs, understanding the implications of pharmacy spending requires looking through the lens of opportunity cost. These are funds that, if not spent on avoidable pharmacy expenses, could instead enhance workforce investments, such as merit increases, more hires, or retirement contributions. Pruitt illustrates this point by suggesting that if an employer identifies $500,000 in unnecessary pharmacy expenses, they could redirect those funds toward more beneficial initiatives that resonate with employee needs and organizational goals.

The conversation must shift toward joint ownership of pharmacy decisions between HR and finance teams. Pruitt recommends that before annual renewals, CHROs and CFOs should collaboratively analyze various factors, including total pharmacy spend, year-over-year trends, and the distribution of costs, alongside recruitment and retention strategies.

Building a Sustainable Strategy

Pruitt warns against defining success solely by minimizing pharmacy costs. Instead, a sustainable pharmacy strategy should enhance predictability—offering accurate forecasts, clear management of specialty medications, and easy access to necessary therapies. The core question should transition from "How much does our pharmacy benefit cost?" to "What is our pharmacy strategy enabling or restricting for our workforce?" Understanding this nuance is pivotal for employers looking to bolster hiring, improve compensation, and enhance employee experiences comprehensively.

A Call to Action for Business Leaders

As companies navigate the ever-evolving landscape of healthcare benefits, recognizing the interconnected nature of pharmacy costs with employee satisfaction and overall business health is critical. By advocating for a more integrated approach to pharmacy benefits, SHARx is prompting HR and CFO leaders to view these issues not simply as procurement decisions, but as vital components of broader workforce strategy. This perspective can ultimately lead to improved employee outcomes, retention, and trust—elements that are increasingly valuable in today's competitive business environment.

About SHARx

Founded to combat the challenges posed by exorbitantly priced prescription drugs, SHARx operates under a mission to prioritize people over profits. By employing an innovative sourcing model, SHARx promotes transparency and introduces common-sense cost containment strategies. With notable advocates from the sports industry supporting their mission, SHARx continues to challenge the status quo, advocating for fairness and accessibility in healthcare. For further information, visit SHARXplan.com.